Works matching IS 14741776 AND DT 2004 AND VI 3 AND IP 6


Results: 19
    1
    2
    3

    Shifting the focus of chemistry.

    Published in:
    Nature Reviews Drug Discovery, 2004, v. 3, n. 6, p. 535, doi. 10.1038/nrd1431
    By:
    • Franz, Simon
    Publication type:
    Article
    4

    Stand by your brand.

    Published in:
    Nature Reviews Drug Discovery, 2004, v. 3, n. 6, p. 466, doi. 10.1038/nrd1437
    By:
    • Petit-Zeman, Sophie
    Publication type:
    Article
    5
    6
    7

    Targeted therapy for brain tumours.

    Published in:
    Nature Reviews Drug Discovery, 2004, v. 3, n. 6, p. 499, doi. 10.1038/nrd1414
    By:
    • Lesniak, Maciej S.;
    • Brem, Henry
    Publication type:
    Article
    8
    9
    10
    11
    12
    13
    14

    Fresh from the pipeline: Efalizumab.

    Published in:
    Nature Reviews Drug Discovery, 2004, v. 3, n. 6, p. 473, doi. 10.1038/nrd1420
    By:
    • Marecki, Sylvia;
    • Kirkpatrick, Peter
    Publication type:
    Article
    15
    16

    Pharmacodynamics: PET power.

    Published in:
    Nature Reviews Drug Discovery, 2004, v. 3, n. 6, p. 476, doi. 10.1038/nrd1425
    By:
    • Brazil, Melanie
    Publication type:
    Article
    17

    In Brief.

    Published in:
    Nature Reviews Drug Discovery, 2004, v. 3, n. 6, p. 478, doi. 10.1038/nrd1427
    By:
    • Jones, Daniel
    Publication type:
    Article
    18
    19

    Richard D. Klausner.

    Published in:
    Nature Reviews Drug Discovery, 2004, v. 3, n. 6, p. 470, doi. 10.1038/nrd1430
    Publication type:
    Article